Advertisement
Product › Details
MAGE-A10 SPEAR™ T-cell therapy
Next higher product group | SPEAR™ T-cell therapy | |
Status | 2016-08-08 development pc existent | |
Organisation | Adaptimmune Therapeutics plc (Nasdaq: ADAP) | |
Group | Adaptimmune (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for SPEAR™ T-cell therapy
- [1] Adaptimmune Therapeutics plc. (11/8/22). "Press Release: Adaptimmune Reports Third-Quarter Financial Results and Business Update". Philadelphia, PA & Oxford....
- [2] Immunocore Ltd.. (3/2/20). "Press Release: Immunocore Secures $130 Million Series B Financing". Oxfordshire & Conshohocken, PA....
- [3] Adaptimmune Therapeutics plc. (8/27/19). "Press Release: Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products Expressing IL-7 and CCL19 as a Next-generation Treatment for Cancer Patients". Philadeliphia, PA & Oxfordshire....
- [4] Vaccitech Ltd.. (8/27/19). "Press Release: Vaccitech Appoints Bill Enright as New Chief Executive Officer". Philadeliphia, PA & Oxfordshire....
- [5] Allogene Therapeutics, Inc.. (8/5/19). "Press Release: Allogene Therapeutics Appoints Rafael G. Amado, M.D. as Executive Vice President of Research and Development and Chief Medical Officer". South San Francisco, CA....
- [6] Adaptimmune Therapeutics plc. (8/1/19). "Press Release: New Executive Team Announced at Adaptimmune. Adrian Rawcliffe to Assume CEO role from September 1, 2019". Philadeliphia, PA & Oxfordshire....
- [7] Adaptimmune Therapeutics plc. (6/27/19). "Press Release: Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer". Philadeliphia, PA & Oxfordshire....
- [8] Adaptimmune Therapeutics plc. (2/27/19). "Press Release: CORRECTING and REPLACING -- Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update". Philadeliphia, PA & Oxford....
- [9] Adaptimmune Therapeutics plc. (9/5/18). "Press Release: Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares". Philadeliphia, PA & Oxford....
- [10] Adaptimmune Therapeutics plc. (8/15/18). "Press Release: Third Dosing Cohort to Be Initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort". Philadeliphia, PA & Oxford....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top